Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.115
+0.095 (9.31%)
May 8, 2025, 4:00 PM EDT - Market closed
Standard BioTools Market Cap
Standard BioTools has a market cap or net worth of $423.50 million as of May 8, 2025. Its market cap has decreased by -42.53% in one year.
Market Cap
423.50M
Enterprise Value
196.97M
1-Year Change
-42.53%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since February 10, 2011, Standard BioTools's market cap has increased from $260.60M to $423.50M, an increase of 62.51%. That is a compound annual growth rate of 3.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 387.40M | -40.54% |
| Dec 31, 2024 | 651.50M | 271.23% |
| Dec 29, 2023 | 175.50M | 89.12% |
| Dec 30, 2022 | 92.80M | -69.05% |
| Dec 31, 2021 | 299.80M | -32.58% |
| Dec 31, 2020 | 444.70M | 83.68% |
| Dec 31, 2019 | 242.10M | -28.58% |
| Dec 31, 2018 | 339.00M | 48.95% |
| Dec 29, 2017 | 227.60M | 7.36% |
| Dec 30, 2016 | 212.00M | -31.88% |
| Dec 31, 2015 | 311.20M | -67.35% |
| Dec 31, 2014 | 953.00M | -2.80% |
| Dec 31, 2013 | 980.50M | 174.19% |
| Dec 31, 2012 | 357.60M | 34.23% |
| Dec 30, 2011 | 266.40M | 2.23% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.10B |
| Johnson & Johnson | 371.55B |
| UnitedHealth Group | 359.04B |
| AbbVie | 331.15B |
| Novo Nordisk | 297.73B |
| Abbott Laboratories | 231.51B |
| AstraZeneca | 221.69B |
| Novartis AG | 221.37B |